Proxima Research served as the Analytical Partner at the Eurasian Pharmaceutical Summit 2024, held from September 17-19 in Tashkent, Uzbekistan. The event, organized by the Global Pharmaceutical Leaders’ Club, brought together over 200 pharmaceutical industry leaders from Central Asia, the Caucasus, and Eastern Europe leaders to discuss key strategies, regulatory changes, and future industry developments. The pharmaceutical markets of Eurasia are evolving amidst continuous challenges and changes that significantly affect their dynamics. In this context, coming together for joint discussions and solutions is essential to move forward confidently.
Key Themes and Discussions. Summit participants actively discussed trends in the pharmaceutical markets’ public and commercial segments in countries such as Kazakhstan, Uzbekistan, Kyrgyzstan, Azerbaijan, Armenia, and others. One of the central topics was the future of pharmaceutical markets in the face of increasing product quality requirements and changing regulatory frameworks. Proxima Research representatives presented data on the pharmaceutical markets of Kazakhstan and Uzbekistan. As part of the summit, Victoria Spivak, Chief Commercial Officer, was a guest in an interview on trends in pharmaceutical markets.
Proxima Research Presentations. KimVitaliy , Director of Proxima Research Uzbekistan, presented an overview of the pharmaceutical markets of Kazakhstan and Uzbekistan for the first half of 2024 based on data from analytical projects such as Market Audit, PromoTest, and RxTest. He highlighted vital market growth indicators, focusing on the increase in local production, market needs, and shifts in demand for medical products in the region.
Ekaterina Markova, Director of Proxima Research Kazakhstan, moderated two panel discussions with key players from the pharmaceutical markets of Eurasian countries, including distributors and pharmacy chains. During the discussions, participants shared insights on significant legislative changes, the impact of state regulation on business, the development of digitalization, biotechnology, and other trends in the pharmaceutical industry.
Exhibition Booth and Prize Draw. At the summit, Proxima Research also hosted an exhibition booth where participants could learn more about the company’s analytical and technological solutions for the pharmaceutical business. Additionally, visitors had the opportunity to participate in a survey, with the chance to win valuable and useful prizes, adding a fun interactive element and fostering stronger engagement with summit attendees.
Unique Opportunities and Meetings. The summit offered unique opportunities for exchanging experiences and addressing pressing issues with key stakeholders in the industry. The event’s format allowed participants to not only engage in discussions and roundtables with regulators but also hold one-on-one meetings with top executives from leading pharmaceutical companies, distributors, and pharmacy chains.
Outcomes and Future Prospects. The Eurasian Pharmaceutical Summit 2024 once again proved to be a platform for exchanging ideas and jointly developing strategies aimed at the continued growth of pharmaceutical markets in Eurasian countries. Proxima Research extends its gratitude to the organizers and all participants for their productive collaboration, the opportunity to discuss key trends, and the sharing of analytical insights with industry experts.
STAY TUNED FOR UPDATES
